Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
DCVC Opportunity Fund II GP, LLC (CIK 1668343) reported $17.2M across 2 reported positions in its SEC 13F filing for 2026-06-30. Largest positions: RXRX ($14.5M, 84.30%), IONQ ($2.7M, 15.70%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | RXRX | Recursion Pharmaceuticals, Inc. | $14.5M | 84.30% | 4.0M | Hold |
| 2 | IONQ | IonQ, Inc. | $2.7M | 15.70% | 50,705 | Trimmed |
Source: SEC Form 13F filings · as of 2026-06-30